Number of the records: 1
Atorvastatín v redukcii LDL - cholesterolu
SYS 0062083 LBL 00000naa^^22^^^^^^^^450 005 20110614092806.3 100 $a 20110426a2011 m y0sloy0103 ba 101 0-
$a slo 102 $a SK 200 1-
$a Atorvastatín v redukcii LDL - cholesterolu $f Štefan Kišoň 305 $a Farsang, C. ... et al. Current Medical Research and Opinion, vol. 23, no. 8 (2007), s. 1945-1956 463 -1
$1 001 sllk_un_cat*0061148 $1 011 $a 1335-924X $1 200 1 $a Lekárnik $e odborno-informačný mesačník pre lekárnikov $v Roč. 16, č. 4 (2011), s. 40 $1 210 $a Bojnice $c Unipharma $d 2011 $1 215 $a s. 2-54 517 1-
$a A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study 606 1-
$3 sllk_un_auth*d000960 $a hypolipidemiká $x použitie terapeutické $x účinky nežiadúce $2 mesh 606 1-
$3 sllk_un_auth*d019161 $a inhibítory hydroxymetylglutaryl-CoA-reduktázy $x použitie terapeutické $x účinky nežiadúce $2 mesh 606 2-
$3 sllk_un_auth*d050171 $a dyslipidémie $x farmakoterapia $2 mesh 608 $3 sllk_un_auth*d020504 $a abstrakty $2 mesh 610 2-
$a atorvastatín 610 2-
$a dyslipoproteinémie 700 -1
$3 sllk_un_auth*p0001190 $a Kišoň $b Štefan $4 010 801 -0
$a SK $b BA006 $c 20110426 $g AACR2
Number of the records: 1